GlassScriptPhysician profile
Alireza Ghajar
NPI 1104448125
$15,302.85
in general payments reported to CMS, 2019-2025
23 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $198 · 2024: $5,032 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,224 · Travel and Lodging: $6,622 · Education: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,224.01 |
| Travel and Lodging | $6,621.75 |
| Education | $457.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,114.58 | 2024-2025 | Micra, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Biotronik INC. | $4,801.93 | 2023-2025 | Pamira, Selectra, Acticor 7 Vr-T Dx |
| Abbott Laboratories | $2,207.45 | 2024-2025 | Merlin@Home, Aveir, Ensite |
| Abiomed | $1,296.98 | 2024-2025 | Impella |
| Boston Scientific Corporation | $278.07 | 2024-2025 | Baylis Medical Company Radiofrequency Puncture Generator, Watchman Flx, General - Tachy |
| E.R. Squibb & Sons, L.L.C. | $245.12 | 2024-2025 | Camzyos |
| Amgen INC. | $213.97 | 2025 | Repatha |
| Atricure, INC. | $212.25 | 2024 | |
| Vital Connect, INC | $166.40 | 2024-2025 | Vitalpatch Rtm |
| Shockwave Medical, INC | $135.01 | 2025 | |
| Novo Nordisk INC | $117.41 | 2025 | Wegovy |
| Terumo Medical Corporation | $105.29 | 2025 | Glidewire, Metacross Otw, Angio-Seal |
| Novartis Pharmaceuticals Corporation | $95.89 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $87.75 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $50.19 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $50.00 | 2025 | |
| Cardiva Medical, INC. | $23.95 | 2023 | Cardiva Vascade 6/7f Vcs |
| Janssen Scientific Affairs, LLC | $22.77 | 2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $17.49 | 2024 | Uptravi, Opsumit |
| Sanofi-Aventis U.S. LLC | $16.53 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $16.06 | 2023 | Symbicort |
| Cvrx, INC. | $14.13 | 2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $13.63 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alireza Ghajar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.